Relationship Between Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) and Hearing Loss and Tinnitus.

Beck’s Depression Inventory Brain-derived neurotrophic factor Hearing Loss Tinnitus Tinnitus handicap inventory

Journal

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
ISSN: 2231-3796
Titre abrégé: Indian J Otolaryngol Head Neck Surg
Pays: India
ID NLM: 9422551

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 12 08 2022
accepted: 16 02 2023
pmc-release: 01 04 2024
medline: 19 5 2023
pubmed: 19 5 2023
entrez: 19 5 2023
Statut: ppublish

Résumé

Tinnitus and hearing loss are common problems that can be investigated via subjective and objective approaches. Previous studies have suggested a potential relationship between serum levels of Brain-Derived Neurotrophic Factor (BDNF) and tinnitus, reporting it as a potential objective biomarker for tinnitus. Therefore, the present study aimed to investigate the serum levels of BDNF in patients with tinnitus and/or hearing loss. Sixty patients were divided into 3 groups: Normal hearing with tinnitus (NH-T), hearing Loss with tinnitus (HL-T), and hearing loss without tinnitus (HL-NT). Moreover, 20 healthy participants were assigned to the control group or NH-NT. All participants were assessed using comprehensive audiological evaluations, serum BDNF level assessment, Tinnitus Handicap Inventory (THI), and Beck's Depression Inventory (BDI). There were significant intergroup differences in serum BDNF levels (p < 0.05), with the HL-T group showing the lowest BDNF levels. Moreover, the NH-T group had lower levels of BDNF compared to the HL-NT group. On the other hand, serum BDNF levels were significantly decreased in patients with an increased hearing threshold (p < 0.05). Also, serum BDNF levels had no significant relationship with tinnitus duration and loudness, as well as THI and BDI scores. The present study was the first to illustrate the importance of serum BDNF levels as a possible biomarker for predicting the severity of hearing loss and tinnitus in the affected patients. Also, it is possible that BDNF assessment can help find effective therapeutic methods for patients with hearing problems. The online version contains supplementary material available at 10.1007/s12070-023-03600-z.

Identifiants

pubmed: 37206834
doi: 10.1007/s12070-023-03600-z
pii: 3600
pmc: PMC10188841
doi:

Types de publication

Journal Article

Langues

eng

Pagination

507-513

Informations de copyright

© Association of Otolaryngologists of India 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Déclaration de conflit d'intérêts

Conflicts of InterestThe authors declare no conflict of interest in any relevant financial or non-financial forms.

Références

J Neurosci. 2012 Jun 20;32(25):8545-53
pubmed: 22723694
Neurobiol Dis. 2010 Oct;40(1):325-30
pubmed: 20598895
J Comp Neurol. 2011 Jun 1;519(8):1455-75
pubmed: 21452215
Noise Health. 2017 May-Jun;19(88):140-148
pubmed: 28615544
Depress Anxiety. 2005;21(4):185-92
pubmed: 16075452
PLoS One. 2013;8(3):e57247
pubmed: 23516401
Neuropharmacology. 1998 Dec;37(12):1553-61
pubmed: 9886678
Int J Dev Neurosci. 1999 Jul;17(4):285-94
pubmed: 10479064
Hear Res. 2014 Dec;318:23-30
pubmed: 25445818
Int Tinnitus J. 2001;7(2):122-7
pubmed: 14689651
Annu Rev Neurosci. 2001;24:677-736
pubmed: 11520916
Neuron. 2013 Oct 30;80(3):718-28
pubmed: 24183022
Thromb Haemost. 2002 Apr;87(4):728-34
pubmed: 12008958
Neuroimage. 2016 Apr 1;129:80-94
pubmed: 26708013
Mol Neurobiol. 2013 Feb;47(1):261-79
pubmed: 23154938
Indian J Otolaryngol Head Neck Surg. 2014 Jan;66(Suppl 1):1-5
pubmed: 24533352
Front Aging Neurosci. 2015 Apr 21;7:58
pubmed: 25954196
Nat Neurosci. 2007 Sep;10(9):1089-93
pubmed: 17726474
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):17005-10
pubmed: 20837532
Neurosci Lett. 2016 May 27;622:15-8
pubmed: 27095590
Mol Pharmacol. 2008 Sep;74(3):595-604
pubmed: 18524887
Development. 2003 Oct;130(19):4741-50
pubmed: 12925599
Sci Rep. 2022 Feb 4;12(1):1934
pubmed: 35121746
Front Cell Neurosci. 2019 Aug 07;13:363
pubmed: 31440144
Trends Neurosci. 2005 Sep;28(9):464-71
pubmed: 16040136
Neural Dev. 2011 Oct 11;6:33
pubmed: 21989106
Indian J Otolaryngol Head Neck Surg. 2019 Nov;71(Suppl 2):1123-1125
pubmed: 31750136
Neuroscience. 2010 Feb 17;165(4):1439-46
pubmed: 19925854
Int J Nanomedicine. 2015 Apr 30;10:3245-67
pubmed: 25995632
Int Tinnitus J. 2011;16(2):93-103
pubmed: 22249867
Exp Neurol. 2010 Nov;226(1):1-5
pubmed: 20654616
Neuroscience. 2007 Mar 16;145(2):715-26
pubmed: 17275194
J Neurobiol. 1997 Dec;33(7):1019-33
pubmed: 9407020
J Affect Disord. 2015 Mar 15;174:432-40
pubmed: 25553404

Auteurs

Nastaran Ranjbar (N)

Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.

Ali Shahbazi (A)

Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Navid Nourizadeh (N)

Otorhinolaryngology-Head and Neck Surgery Department , Imam Reza Educational Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Hossein Namvar Arefi (H)

Department of Audiology, School of Rehabilitation Sciences , Iran University of Medical Science, Tehran, Iran.

Mohammad Taghi Kheirkhah (MT)

Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran.

Classifications MeSH